Why Estée Lauder Is Letting Go of Too Faced, Smashbox and Dr. Jart+
Estée Lauder’s reported move to sell Too Faced, Smashbox and Dr. Jart+ is part of a broader portfolio shake-up. The company is said to have received final bids, with a deal expected to wrap up within weeks. Initially marketed as a single package, the brands were later split, with Too Faced and Smashbox offered together and Dr. Jart+ shopped separately. Industry reports note that Too Faced and Dr. Jart+ have underperformed within Estée Lauder’s larger lineup, which includes blockbuster names like MAC, La Mer and Clinique. At the same time, Estée Lauder is in the midst of a Profit Recovery and Growth Plan focused on cutting costs, streamlining operations and prioritising core franchises. Selling underperforming assets frees up capital and management attention, potentially paving the way for a future merger with another beauty giant and signalling ongoing consolidation across the sector.
Who Wants to Buy Your Favorite Beauty Brands?
Behind the scenes, several types of buyers are reportedly circling these cult-favorite labels. According to industry sources, at least one party has looked at acquiring all three brands, while multiple bidders are concentrating on the colour cosmetics duo, Too Faced and Smashbox. Others are evaluating Dr. Jart+ on a standalone basis, reflecting its different profile as a skincare-driven, derm-inspired brand. Investment banks are said to be running a structured auction process, with various financial and strategic investors weighing how each brand would fit into their existing portfolios or growth plans. The split marketing strategy suggests Estée Lauder recognises that makeup and skincare appeal to different buyers, each with distinct capabilities in product development, marketing and distribution. For consumers, the outcome matters because each new owner will bring its own priorities—whether that is aggressive expansion, niche positioning or cost-focused restructuring—which can directly influence the products that land on shelves.
Dr. Jart+ and the Push to Bring It Back Under Korean Stewardship
Dr. Jart+ sits at the centre of a separate, highly watched negotiation. A private equity firm, PTA Partners, is reportedly pursuing a joint acquisition of Have & Be, the company behind Dr. Jart+, potentially shifting the brand back into Korean hands. Since Estée Lauder took full control in 2019, Dr. Jart+ has struggled, with revenues and profitability reportedly declining as the brand failed to keep pace with fast-moving skincare trends and lost momentum in its home market. Observers argue that global ownership weakened local marketing and slowed innovation. PTA Partners believes it can tap into a sophisticated K-beauty ecosystem—from advanced manufacturers to digital-first influencer campaigns—to revive growth and reconnect Dr. Jart+ with trend-sensitive consumers. For fans, a return to local stewardship could mean a renewed focus on signature categories like derm-style moisturisers and masks, plus a faster response to emerging skincare movements and formats.
What a Beauty Brand Sale Could Mean for Prices, Products and Access
For shoppers, the big questions are simple: Will my favourites still be available, will they change and will they cost more? After an Estée Lauder divestiture, new owners often reassess everything from hero product lines to store footprints. Some may double down on bestsellers, while trimming slow-moving shades or SKUs. Others could tweak packaging, reformulate to meet their own sourcing or regulatory standards, or shift production to different facilities. Pricing strategies may also change—especially if buyers are private equity firms seeking to boost margins, or if they plan to reposition the brands as more premium or more accessible. In the short term, you might see promotional activity as ownership transitions. Over time, differences are more likely to show up in where the brands are sold, how heavily they are marketed and how quickly they launch new collections or skincare innovations.
How This Fits Into a Bigger Beauty Industry Shake-Up
The potential sale of Too Faced, Smashbox and Dr. Jart+ is not happening in isolation. Estée Lauder has signalled a comprehensive review of its portfolio, while also entering exploratory talks about a possible business combination with another multinational beauty player. A merged entity has been speculated in reports as having a substantial combined value, underlining the scale of consolidation underway in the sector. At the same time, Estée Lauder is executing its Profit Recovery and Growth Plan, which includes cost reductions, standardised processes and significant workforce cuts. All of this reflects rising pressure on legacy beauty houses to become leaner, more agile and more focused on top-performing brands. For consumers, it means the landscape of familiar labels may continue to shift—some lines moving to new homes, others being quietly sunsetted—as companies chase growth in a market increasingly shaped by niche players, digital-native upstarts and evolving consumer preferences.